Cisen Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Cisen Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million ≈ $45.64 Million USD) by net assets (CN¥6.19 Billion ≈ $906.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cisen Pharmaceutical Co Ltd (2011–2025)
Cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Cisen Pharmaceutical Co Ltd for real-time trading data and today's change.
Cisen Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Cisen Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Cisen Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Run Long Construction Co Ltd
TW:1808
|
0.262x |
|
IPERIONX LTD SP.ADR/10
F:30Z0
|
N/A |
|
Hunan New Wellful Co Ltd
SHG:600975
|
0.064x |
|
Econergy Renewable Energy Ltd
TA:ECNR
|
-0.003x |
|
Jaya Real Property Tbk
JK:JRPT
|
0.026x |
|
JM AB (publ)
ST:JM
|
-0.005x |
|
Janux Therapeutics Inc
NASDAQ:JANX
|
-0.013x |
|
Henan Jindan Lactic Acid Technology
SHE:300829
|
0.052x |
Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2025. Review Cisen Pharmaceutical Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.23 Billion ≈ $911.75 Million |
CN¥466.37 Million ≈ $68.25 Million |
0.075x | -21.50% |
| 2024-12-31 | CN¥5.99 Billion ≈ $876.08 Million |
CN¥570.85 Million ≈ $83.53 Million |
0.095x | +21.85% |
| 2023-12-31 | CN¥5.77 Billion ≈ $843.81 Million |
CN¥451.24 Million ≈ $66.03 Million |
0.078x | +62.23% |
| 2022-12-31 | CN¥5.36 Billion ≈ $783.73 Million |
CN¥258.35 Million ≈ $37.80 Million |
0.048x | +4.39% |
| 2021-12-31 | CN¥5.06 Billion ≈ $739.79 Million |
CN¥233.60 Million ≈ $34.18 Million |
0.046x | -48.52% |
| 2020-12-31 | CN¥4.80 Billion ≈ $702.68 Million |
CN¥431.01 Million ≈ $63.07 Million |
0.090x | +126.48% |
| 2019-12-31 | CN¥4.57 Billion ≈ $669.29 Million |
CN¥181.26 Million ≈ $26.52 Million |
0.040x | -59.51% |
| 2018-12-31 | CN¥4.15 Billion ≈ $608.01 Million |
CN¥406.68 Million ≈ $59.51 Million |
0.098x | -17.08% |
| 2017-12-31 | CN¥3.72 Billion ≈ $544.98 Million |
CN¥439.61 Million ≈ $64.33 Million |
0.118x | -7.08% |
| 2016-12-31 | CN¥2.30 Billion ≈ $336.34 Million |
CN¥291.97 Million ≈ $42.72 Million |
0.127x | +0.13% |
| 2015-12-31 | CN¥2.10 Billion ≈ $307.11 Million |
CN¥266.24 Million ≈ $38.96 Million |
0.127x | +775.81% |
| 2014-12-31 | CN¥1.90 Billion ≈ $278.19 Million |
CN¥27.54 Million ≈ $4.03 Million |
0.014x | -69.23% |
| 2013-12-31 | CN¥1.73 Billion ≈ $252.63 Million |
CN¥81.26 Million ≈ $11.89 Million |
0.047x | +125.43% |
| 2012-12-31 | CN¥1.58 Billion ≈ $231.88 Million |
CN¥33.09 Million ≈ $4.84 Million |
0.021x | -63.20% |
| 2011-12-31 | CN¥1.34 Billion ≈ $196.74 Million |
CN¥76.28 Million ≈ $11.16 Million |
0.057x | -- |
About Cisen Pharmaceutical Co Ltd
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, anesthetic and a… Read more